Table 3. Time distribution of relapse occurrence following initiation of treatment, with clustering between 3rd and 5th months.
|
Variable |
Association (OR) |
95% CI |
p-value |
|
ESR >20 mm/h |
2.32 |
1.01–5.34 |
0.048 |
|
TNF-a inhibitor |
4.12 |
1.38–12.30 |
0.011 |
|
Cyclosporine |
3.44 |
1.22–9.76 |
0.019 |
|
ACE >52 U/L |
2.05 |
0.98–4.29 |
0.060 (borderline significance) |
TNF-a: Tumor necrosis factor alpha; OR: Odds ratio; CI: Confidence interval; ACE: Angiotensin converting enzyme; ESR: Erythrocyte sedimentation rate